A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

Clinical trial NCT01251614 · COMPLETED

Trial details

NCT number: NCT01251614
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2010-12-01
Primary completion: 2013-12-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.